Terms: = Leukemia AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
210 results:
1. [Proportion and Clinical Significance of γδT17/Th17/Tc17 Cells in Peripheral Blood of Uygur Patients with Chronic Lymphoblastic leukemia].
Zeng XJ; Zhang R; Xierenguli A; Maliya M; Zhao F; Guli B; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):85-89. PubMed ID: 38387904
[TBL] [Abstract] [Full Text] [Related]
2. Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.
Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
[No Abstract] [Full Text] [Related]
3. [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].
Li F; Gao YJ; Li SS; Xi YY; Yang XW; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1771-1779. PubMed ID: 38071059
[TBL] [Abstract] [Full Text] [Related]
4. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
[No Abstract] [Full Text] [Related]
5. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
[TBL] [Abstract] [Full Text] [Related]
6. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic leukemia.
Marinelli LM; Romain JT; Ehman W; Ortega V; Velagaleti G; Gibbons TF; Nazario-Toole A; Holmes AR
Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
Kutluk T; Sahin B; Kirazli M; Ahmed F; Aydin S; Yesil Çinkir H; Sezgin G; Bayram I; Ebinç S; Isikdogan A; Sasmaz I; Okan V; Ilhan G; Ören AC; Akbayram S; Harputluoglu H; Ural C; Ayyildiz O; Aktas G; Uçar MA; Güvenç B; Köse D; Acipayam C; Güncan S; Erçolak V; Berber I; Akdeniz A; Akyay A; Üzel VH; Söker M; Sengelen M; Yalçin S; Sullivan R
JAMA Netw Open; 2023 May; 6(5):e2312903. PubMed ID: 37219908
[TBL] [Abstract] [Full Text] [Related]
8. Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context.
Gupta R; Garg N; Singh A; Jain SL
Indian J Pathol Microbiol; 2023; 66(2):291-294. PubMed ID: 37077070
[TBL] [Abstract] [Full Text] [Related]
9. Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study.
Delapierre B; Troussard X; Damaj G; Dejardin O; Tron L
Cancer Epidemiol; 2023 Feb; 82():102292. PubMed ID: 36410088
[TBL] [Abstract] [Full Text] [Related]
10. TNF-α-308A allele Carrier Induced to Development of Chronic Lymphocytic leukemia in Sudanese Population at Earlier Age.
Basabaeen AA; Abdelgader EA; Ahmed Babekir E; Abdelateif NM; Osman Abdelrahim S; Awadalkareem Omer AY; Altayeb OA; Fadul EA; Ibrahim IK
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3449-3455. PubMed ID: 36308371
[TBL] [Abstract] [Full Text] [Related]
11. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
12. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease.
O'Connor DM; Murad F; Danesh MJ; Butler W; Smile TD; Ilori EO; Gastman BR; Vidimos A; Waldman AB; Schmults CD; Koyfman S; Ruiz ES
J Am Acad Dermatol; 2022 Dec; 87(6):1295-1302. PubMed ID: 36063987
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic leukemia.
Hussein S; Abdelazem AS; Abdelmoneem S; Abdelnabi AM; Khamis T; Obaya AA; Ebian HF
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2735-2742. PubMed ID: 36037128
[TBL] [Abstract] [Full Text] [Related]
14. Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
Cegla P; Scibisz-Dziedzic K; Witkowska K; Kubiak A; Wierzchoslawska E; Kycler W; Chrapko B; Czepczyński R
Nucl Med Rev Cent East Eur; 2022; 25(1):25-30. PubMed ID: 35137934
[TBL] [Abstract] [Full Text] [Related]
15. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Schjesvold FH; Dimopoulos MA; Delimpasi S; Robak P; Coriu D; Legiec W; Pour L; Špička I; Masszi T; Doronin V; Minarik J; Salogub G; Alekseeva Y; Lazzaro A; Maisnar V; Mikala G; Rosiñol L; Liberati AM; Symeonidis A; Moody V; Thuresson M; Byrne C; Harmenberg J; Bakker NA; Hájek R; Mateos MV; Richardson PG; Sonneveld P;
Lancet Haematol; 2022 Feb; 9(2):e98-e110. PubMed ID: 35032434
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials.
Chen YT; Valent ET; van Beers EH; Kuiper R; Oliva S; Haferlach T; Chng WJ; van Vliet MH; Sonneveld P; Larocca A
Int J Lab Hematol; 2022 Feb; 44(1):127-134. PubMed ID: 34448362
[TBL] [Abstract] [Full Text] [Related]
17. Level of Scientific Evidence Underlying the National Comprehensive Cancer Network Clinical Practice Guidelines for Hematologic Malignancies: Are We Moving Forward?
Chengappa M; Desai A; Go R; Poonacha T
Oncology (Williston Park); 2021 Jul; 35(7):390-396. PubMed ID: 34270186
[TBL] [Abstract] [Full Text] [Related]
18. Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
Song S; Zhang J; Su Q; Zhang W; Jiang Y; Fan G; Qian C; Li B; Zhuang W
Br J Cancer; 2021 May; 124(11):1843-1853. PubMed ID: 33785876
[TBL] [Abstract] [Full Text] [Related]
19. [Evolvement of a five-way translocation t(5;9;22;6;17) from a four-way Philadelphia translocation t(5;9;22;6) in a rare case of chronic myeloid leukemia].
Kong S; Gu Y; Qin Y; Wang Z; Feng L; Jiang Q; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1395-1398. PubMed ID: 33306831
[TBL] [Abstract] [Full Text] [Related]
20. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic leukemia].
Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940
[TBL] [Abstract] [Full Text] [Related]
[Next]
